Performance assessment of novel test

Clinical trials for Performance assessment of novel test explained in plain language.

Never miss a new study

Get alerted when new Performance assessment of novel test trials appear

Sign up with your email to follow new studies for Performance assessment of novel test, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Smarter prostate cancer screening: a blood test that may cut unnecessary biopsies

Diagnosis Ongoing

This study is testing whether a new blood test called ClarityDX Prostate can better identify men who have clinically significant prostate cancer. The test is given to men aged 40-75 with elevated PSA levels (3 ng/mL or higher) who are already scheduled for a prostate biopsy. Rese…

Matched conditions: PERFORMANCE ASSESSMENT OF NOVEL TEST

Sponsor: Nanostics • Aim: Diagnosis

Last updated Jul 26, 2026 00:00 UTC

Performance assessment of novel test

Get alerted when new Performance assessment of novel test trials appear

Smarter prostate cancer screening: a blood test that may cut unnecessary biopsies